Arkolith/Insider Trading/KURA/Form 4

Burrows Francis

Chief Scientific OfficerKura Oncology, Inc. (KURA) · full profile →Form 4 · filed Dec 19, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$232K
Net Open-Market Flow
-$232K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 18, 2025Sell(S)24K$9.78$232K34K
Dec 18, 2025Option exercise(M)35K$4.80$168K57K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 18, 2025Option exercise(M)35K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-326948) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML